Keywords
Quality Indicators in Health Care
Diabetes mellitus
Primary Health Care
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Identify, in the scientific literature, the quality indicators for monitoring the clinical service provided by a pharmacist to patients with diabetes mellitus, in the context of primary health care. Methods: Integrative review, searching for scientific articles in five health databases: PubMed, SCOPUS, Web of Science, CINAHL and LILACS. In the end, the sample consisted of 11 surveys. The analysis and synthesis of the data occurred in a descriptive way and through figures and charts. Results: 23 indicators were identified, classified according to the subject (appointments, monitoring exams, interventions, prescriptions, service, adherence to treatment, clinical and nutritional improvement). The indicators were also organized according to type: structure, process and results. The studies show the relationship between quality indicators and their clinical and humanistic content, as well as the application of indicators that made it possible to measure the service as well as control chronic diseases and improve clinical-therapeutic results. Final considerations: Conducting this review generated a body of evidence that reinforces the importance of clinical pharmacy and its quality indicators for the control of diabetes mellitus in patients treated in primary health care.
References
BARROS DSL, et al. Serviços farmacêuticos clínicos na atenção primária à saúde do Brasil. Trab Educação Saúde, 2020; 18(1).
DESTRO DR, et al. Desafios para o cuidado farmacêutico na Atenção Primária à Saúde. Physis, 2021; 31(3).
DICKERSON LM, et al. Measuring Diabetes Care in the National Interdisciplinary Primary Care Practice-Based Research Network (NIPC-PBRN). Pharmacother, 2011; 31(1): 23-30.
DONABEDIAN A. The definition of quality and approaches to its assessment. Ann Arbor, Michigan: Health Administration Press, 1980; 1(1).
GANONG LH. Integrative reviews of nursing research. Res. Nurs. Health, 1987; 10(1): 1-11.
GATWOOD JD, et al. Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes. BMC Health Serv Res., 2018; 18(1): 855-64.
KAKA AS, et al. Risk prediction models for diabetic foot ulcer development or amputation: a review of reviews. J Foot Ankle Res., 2023; 16(1): 13.
KALRA S, et al. Rights and responsabilities in diabetes care. J Pak Med Assoc., 2022; 7(7): 1447-8.
KLOPPER R, et al. The matrix method of literature review. Alternation., 2007; 14(1): 262-276.
LINDENMEYER A, et al. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Therap., 2006; 31(1): 409-19.
LOCKWOOD C, et al. Chapter 2: Systematic eviews of qualitative evidence. In: Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis., 2020; 1(1).
MALTA DC, et al. Diabetes autorreferido e fatores associados na população adulta brasileira: Pesquisa Nacional de Saúde, 2019. Ciênc Saúde Coletiva, 2022a; 7(7).
MALTA DC, et al. Indicadores da linha de cuidado de pessoas com diabetes no Brasil: Pesquisa Nacional de Saúde 2013 e 2019. Epidemiol Serv Saúde, 2022b; 21(1): e2021382.
MENDES KDS, et al. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm., 2008; 17(4): 758-64.
MONTE SV, et al. Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care–based collaboration model. J Am Pharm Assoc., 2009; 49(1): 200-208.
MORELLO CM, et al. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management “Tune Up” Clinic in Complex Patients. Ann Pharm., 2016; 50(1): 8-16.
PAGE MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021; 372(71): 1-9.
POUSINHO S, et al. Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review. Pharm Prac., 18(3): 1-9.
ROUX C, et al. Optimisation des entretiens pharmaceutiques à l'officine Bilan et retour de cette mission mise en place en 2013 et perspectives de développement dans le département du Calvados. Ann Pharm Fr., 2020; 78(6): 487-496.
SBD. SOCIEDADE BRASILEIRA DE DIABETES. Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. Editora Científica, 2019.
SHERRILL CH. Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes. J Manag Care Spec Pharm., 2020; 26(5): 600-609.
SMITS KPJ, et al. Development and validation of prescribing quality indicators for patients with type 2 diabetes. Int J Clin Prac., 2016; 71(1).
TAN ECK, et al. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm., 2013; 20(13): 1-16.
SANTOS AL, et al. Adesão ao tratamento de diabetes Mellitus e relação com a assistência na atenção primária. Rev Min Enferm., 2020; 24(1).
SOMANAWAT J, et al. Process, quality and challenges of diabetes care in primary care: a study of district health network in Thailand. Prim Health Care Res Develop., 2020; 21(46): 1-9.
WONG PYA. Diabetes: know thy foe. Ann Acad Med Singap., 2023; 52(2): 57-59.
ZARE M, et al. Multidisciplinary diabetes care in a safety net clinic: lessons learned from a quality improvement initiative. JCOM, 2018; 25(5): 206-211.